These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Hurlin PJ; Quéva C; Eisenman RN Genes Dev; 1997 Jan; 11(1):44-58. PubMed ID: 9000049 [TBL] [Abstract][Full Text] [Related]
3. Chromatin dynamics at the hTERT promoter during transcriptional activation and repression by c-Myc and Mnt in Xenopus leavis oocytes. Wahlström T; Belikov S; Arsenian Henriksson M Exp Cell Res; 2013 Dec; 319(20):3160-9. PubMed ID: 23860446 [TBL] [Abstract][Full Text] [Related]
4. Evidence of mnt-myc antagonism revealed by mnt gene deletion. Hurlin PJ; Zhou ZQ; Toyo-Oka K; Ota S; Walker WL; Hirotsune S; Wynshaw-Boris A Cell Cycle; 2004 Feb; 3(2):97-9. PubMed ID: 14712062 [TBL] [Abstract][Full Text] [Related]
6. Mnt takes control as key regulator of the myc/max/mxd network. Wahlström T; Henriksson M Adv Cancer Res; 2007; 97():61-80. PubMed ID: 17419941 [TBL] [Abstract][Full Text] [Related]
7. Switch from Mnt-Max to Myc-Max induces p53 and cyclin D1 expression and apoptosis during cholestasis in mouse and human hepatocytes. Yang H; Li TW; Ko KS; Xia M; Lu SC Hepatology; 2009 Mar; 49(3):860-70. PubMed ID: 19086036 [TBL] [Abstract][Full Text] [Related]
8. Mnt: a novel Max-interacting protein and Myc antagonist. Hurlin PJ; Qúeva C; Eisenman RN Curr Top Microbiol Immunol; 1997; 224():115-21. PubMed ID: 9308234 [TBL] [Abstract][Full Text] [Related]
9. Mnt transcriptional repressor is functionally regulated during cell cycle progression. Popov N; Wahlström T; Hurlin PJ; Henriksson M Oncogene; 2005 Dec; 24(56):8326-37. PubMed ID: 16103876 [TBL] [Abstract][Full Text] [Related]
10. Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis. Hurlin PJ; Zhou ZQ; Toyo-oka K; Ota S; Walker WL; Hirotsune S; Wynshaw-Boris A EMBO J; 2003 Sep; 22(18):4584-96. PubMed ID: 12970171 [TBL] [Abstract][Full Text] [Related]
11. Combined IFN-gamma and retinoic acid treatment targets the N-Myc/Max/Mad1 network resulting in repression of N-Myc target genes in MYCN-amplified neuroblastoma cells. Cetinkaya C; Hultquist A; Su Y; Wu S; Bahram F; Påhlman S; Guzhova I; Larsson LG Mol Cancer Ther; 2007 Oct; 6(10):2634-41. PubMed ID: 17938259 [TBL] [Abstract][Full Text] [Related]
13. A critical role for Mnt in Myc-driven T-cell proliferation and oncogenesis. Link JM; Ota S; Zhou ZQ; Daniel CJ; Sears RC; Hurlin PJ Proc Natl Acad Sci U S A; 2012 Nov; 109(48):19685-90. PubMed ID: 23150551 [TBL] [Abstract][Full Text] [Related]
14. Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression. Toyo-oka K; Bowen TJ; Hirotsune S; Li Z; Jain S; Ota S; Escoubet-Lozach L; Garcia-Bassets I; Lozach J; Rosenfeld MG; Glass CK; Eisenman R; Ren B; Hurlin P; Wynshaw-Boris A Cancer Res; 2006 Jun; 66(11):5565-73. PubMed ID: 16740691 [TBL] [Abstract][Full Text] [Related]
15. Mnt: master regulator of the Max network. Nilsson JA; Cleveland JL Cell Cycle; 2004 May; 3(5):588-90. PubMed ID: 15107624 [TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of the ornithine decarboxylase gene by c-Myc/Max/Mad network and retinoblastoma protein interacting with c-Myc. Auvinen M; Järvinen K; Hotti A; Okkeri J; Laitinen J; Jänne OA; Coffino P; Bergman M; Andersson LC; Alitalo K; Hölttä E Int J Biochem Cell Biol; 2003 Apr; 35(4):496-521. PubMed ID: 12565711 [TBL] [Abstract][Full Text] [Related]
17. Analysis of the Max-binding protein MNT in human medulloblastomas. Sommer A; Waha A; Tonn J; Sörensen N; Hurlin PJ; Eisenman RN; Lüscher B; Pietsch T Int J Cancer; 1999 Sep; 82(6):810-6. PubMed ID: 10446446 [TBL] [Abstract][Full Text] [Related]
18. Development and survival of MYC-driven lymphomas require the MYC antagonist MNT to curb MYC-induced apoptosis. Nguyen HV; Vandenberg CJ; Ng AP; Robati MR; Anstee NS; Rimes J; Hawkins ED; Cory S Blood; 2020 Mar; 135(13):1019-1031. PubMed ID: 31978211 [TBL] [Abstract][Full Text] [Related]
19. Loss of the Max-interacting protein Mnt in mice results in decreased viability, defective embryonic growth and craniofacial defects: relevance to Miller-Dieker syndrome. Toyo-oka K; Hirotsune S; Gambello MJ; Zhou ZQ; Olson L; Rosenfeld MG; Eisenman R; Hurlin P; Wynshaw-Boris A Hum Mol Genet; 2004 May; 13(10):1057-67. PubMed ID: 15028671 [TBL] [Abstract][Full Text] [Related]